ibrutinib,zanubrutinib
abbvie,beigene,janssen
['leukemia', 'lymphoma', 'zanubrutinib', 'cll', ' ibru', 'alpine']
jennifer brown, md, phd share results of the alpine randomized phase 3 study, which shows zanubrutinib demonstrates superior progression-free survival for treatment of relapsed/refractory #cll #ash22 
Dana-Farber Cancer Institute - a leading center for expert, compassionate cancer care and advanced research.
Appts: 877-442-3324 | https://t.co/HvCwkLltic